| Literature DB >> 32221668 |
G Pugh1, N Below2, A Fisher3, J Reynolds4, S Epstone4.
Abstract
PURPOSE: To evaluate the uptake and effect of RENEW, a 12-week exercise referral programme for young adult cancer survivors delivered by Trekstock, a UK-based cancer charity.Entities:
Keywords: Exercise programme; Physical activity; Young adult cancer survivors
Mesh:
Year: 2020 PMID: 32221668 PMCID: PMC7686001 DOI: 10.1007/s00520-020-05373-5
Source DB: PubMed Journal: Support Care Cancer ISSN: 0941-4355 Impact factor: 3.603
Fig. 1Flow of participants. Data provided in brackets refers to those who completed the evaluation outcome measures
Participant characteristics and health demographics
| Number | Mean (SD) or % | |
|---|---|---|
| General demographics | ||
| Age (years) | 48 | 29.04 (5.37) |
| BMI (kg/m2) | 48 | 26.09 (6.86) |
| Range (kg/m2) | 16.8–45.7 | |
| Gender | ||
| Female | 40 | 83.3% |
| Male | 8 | 16.7% |
| Ethnicity | ||
| White | 39 | 81.3% |
| Mixed | 2 | 4.2% |
| Bangladeshi | 1 | 2.1% |
| Indian | 3 | 6.3% |
| Black African | 2 | 4.2% |
| Black Caribbean | 1 | 2.1% |
| Education | ||
| GCSE/school certificate | 2 | 4.2% |
| Vocational qualifications | 1 | 2.1% |
| A-Level/high school certificate oe | 6 | 12.5% |
| Bachelor degree oe | 18 | 37.5% |
| Masters/PhD/PGCE oe | 10 | 20.8% |
| Employment | ||
| Employed full time | 10 | 20.8% |
| Employed part time | 4 | 8.3% |
| Self-employed | 7 | 14.6% |
| Full-time education | 4 | 8.3% |
| Part-time education | 1 | 2.1% |
| Unemployed, looking for work | 2 | 4.2% |
| Voluntary work | 1 | 2.1% |
| Unable/too ill to work | 8 | 16.7% |
| Marital status | ||
| Married/living with partner | 12 | 25% |
| In a relationship | 5 | 10.4% |
| Single | 21 | 43.8% |
| Divorced | 1 | 2.1% |
| Prefer not to say | 1 | 2.1% |
| Living arrangements | ||
| Living with partner | 10 | 20.8% |
| Living with family | 16 | 33.3% |
| Living with friends | 5 | 22.7% |
| Living alone | 6 | 12.5% |
| Cancer type | ||
| Breast | 8 | 16.7% |
| Lymphoma | 9 | 18.8% |
| Leukaemia | 6 | 12.5% |
| Bowel | 4 | 8.3% |
| Bone | 2 | 4.2% |
| Carcinoma | 2 | 4.2% |
| Brain | 1 | 2.1% |
| Ovarian | 1 | 2.1% |
| Womb | 2 | 4.2% |
| Soft tissue sarcoma | 1 | 2.1% |
| Lung | 1 | 2.1% |
| Cervical | 1 | 2.1% |
| Testicular | 2 | 4.2% |
| Other | 8 | 16.6% |
| Cancer stage | ||
| 0 | 1 | 2.1% |
| 1 | 7 | 14.6% |
| 2 | 12 | 25% |
| 3 | 13 | 16.7% |
| 4 | 5 | 10.4% |
| Do not know | 12 | 25% |
| Treatment status | ||
| Did not answer | 4 | 8.4% |
| Completed | 32 | 66.7% |
| Active | 12 | 25% |
| Time since treatment | ||
| On active treatment | 7 | 26.9% |
| 1–3 months | 1 | 3.8% |
| 4–11 months | 10 | 38.5% |
| 1–5 years | 8 | 30.8% |
| Treatment received | ||
| Chemotherapy | 37 | 77.1% |
| Radiotherapy | 21 | 43.8% |
| Surgery | 28 | 58.3% |
| Hormone therapy | 9 | 18.8% |
| Other | 11 | 22.9% |
Where percentage < 100 denotes missing data; where participants with > 100% had the option to select more than one answer
Change in physical activity behaviour (mean ± SE)
| Outcome | Baseline | Post-programme | Follow-up | T0–T1 | T1–T2 | T0–T2 | |||
|---|---|---|---|---|---|---|---|---|---|
| Physical activity (GLTEQ) | 37.94 ± 3.07 | 56.35 ± 1.88 | 60.00 ± 1.56 | 18.40 ± 3.25 | 0.000 | 3.64 ± 2.19 | 0.099 | 22.05 ± 3.34 | 0.000 |
| Frequency of PA per week | |||||||||
| Mild | 4.40 ± 2.47 | 6.25 ± 2.93 | 6.00 ± 2.44 | − 2.13 ± 2.73 | 0.004 | 0.11 ± 1.05 | 0.760 | 2.38 ± 2.84 | 0.011 |
| Moderate | 3.67 ± 2.26 | 4.15 ± 2.91 | 4.42 ± 1.41 | − 0.52 ± 3.25 | 0.489 | 0.44 ± 1.42 | 0.377 | 0.05 ± 2.2 | 0.409 |
| Vigorous | 1.03 ± 1.54 | 2.00 ± 1.16 | 2.26 ± 1.23 | − 0.71 ± 1.34 | 0.024 | 0.11 ± 0.60 | 0.594 | 1.03 ± 1.39 | 0.020 |
| Sedentary behavioura | 13.3 ± 4.6 | 15.0 ± 10.9 | 16.2 ± 12.0 | 0.06 ± 8.16 | 0.953 | 1.23 ± 2.49 | 0.249 | 0.65 ± 5.09 | 0.574 |
aTotal hours of sitting time, TV viewing and computer use per day
Change in physical function (mean ± SE)
| Outcome | Baseline | Post-programme | Mean diff ± SD | |
|---|---|---|---|---|
| T0–T1 | ||||
| Resting systolic BP | 113.66 ± 1.57 | 113.77 ± 1.54 | 0.10 ± 1.42 | 0.944 |
| Resting diastolic BP | 76.93 ± 1.28 | 79.23 ± 1.15 | 2.30 ± 1.06 | 0.031 |
| Resting HR | 80.23 ± 1.36 | 79.36 ± 1.25 | 0.65 ± 1.07 | 0.543 |
| Peak expiratory flow | 407.66 ± 10.42 | 456.70 ± 12.45 | 49.03 ± 8.44 | 0.000 |
| Sit and reach (cm) | 13.1 ± 1.80 | 19.8 ± 1.64 | 6.76 ± 0.95 | 0.000 |
| 6 min walk test (km) | 0.525 ± 0.29 | 0.65 ± 0.28 | 0.13 ± 0.03 | 0.000 |
| Muscle mass | 26.33 ± 0.05 | 26.85 ± 0.63 | 0.51 ± 0.38 | 0.177 |
| Fat mass | 25.42 ± 1.88 | 25.34 ± 1.85 | 0.07 ± 0.65 | 0.909 |
| Weight (kg) | 73.48 ± 2.43 | 74.01 ± 2.39 | − 0.52 ± 0.66 | 0.427 |
| BMI | 26.09 ± 0.88 | 26.17 ± 0.87 | − 0.08 ± 0.38 | 0.834 |
Self-efficacy and motivation (mean ± SD)
| Outcome | Baseline | Post-programme | Follow-up | T0–T1 | T1–T2 | T2–T0 | |||
|---|---|---|---|---|---|---|---|---|---|
| Self-efficacya | 56.82 ± 18.54 | 54.4 ± 21.03± | 57.30 ± 24.50 | 4.06 ± 3.5 | 0.247 | 0.11 ± 2.51 | 0.965 | 4.17 ± 2.75 | 0.129 |
| Motivation and behavioural regulationb | |||||||||
| Amotivation: lacking any intention to engage in PA. | 3.78 ± 0.72 | 3.53 ± 0.12 | 3.26 ± 0.15 | 0.25 ± 0.19 | 0.075 | 0.26 ± 0.19 | 0.169 | 0.52 ± 0.17 | 0.004 |
| External regulation: engaging in PA only in order to satisfy external pressures or to achieve externally imposed rewards. | 3.09 ± 0.13 | 3.01 ± 0.143 | 2.97 ± 0.17 | 0.07 ± 0.18 | 0.684 | 0.04 ± 0.23 | 0.842 | 0.12 ± 0.24 | 0.618 |
| Introjected regulation: internalisation of external controls, which are then applied through self-imposed pressures in order to avoid guilt or maintain self-esteem. | 1.72 ± 0.15 | 1.95 ± 0.20 | 1.53 ± 0.11 | 0.23 ± 0.21 | 0.151 | 0.18 ± 0.21 | 0.398 | 0.42 ± 0.27 | 0.271 |
| Identified regulation: conscious acceptance of PA as being important in order to achieve personally valued outcomes. | 1.02 ± 0.11 | 1.19 ± 0.17 | 1.01 ± 0.09 | 0.17 ± 0.20 | 0.406 | 0.17 ± 0.50 | 0.208 | 0.00 ± 0.14 | 0.956 |
| Intrinsic regulation: taking part in PA for the enjoyment and satisfaction inherent in engaging in the behaviour itself. | 1.53 ± 0.16 | 1.44 ± 0.17 | 1.64 ± 0.15 | 0.09 ± 0.21 | 0.439 | 0.19 ± 0.23 | 0.831 | 0.09 ± 0.19 | 0.497 |
aSEE score range is from 0 to 90 (0 indicating no confidence to exercise for each outcome; 90 indicating high confidence to exercise when faced with each listed barrier)
bThe BREQ is scored on a scale of 1–6. For each domain, a higher score indicates more dominance
Change in sleep, fatigue and HRQoL
| Baseline | Post-programme | Follow-up | T0–T1 | T1–T2 | T0–T2 | ||||
|---|---|---|---|---|---|---|---|---|---|
| Mean ± SE | Mean ± SE | Mean ± SE | |||||||
| Fatigue (FACIT-F) | 23.17 ± 1.19 | 33.34 ± 1.11 | 31.22 ± 0.96 | 10.1 ± 1.45 | < 0.005 | 21. ±1.27 | 0.100 | 8.04 ± 1.49 | < 0.01 |
| Sleep (PSQI) | 7.15 ± 0.36 | 8.35 ± 0.38 | 6.10 ± 0.35 | 1.2 ± 0.47 | 0.013 | 2.25 ± 0.56 | 0.000 | 1.05 ± 0.49 | 0.034 |
| HRQoL (EURO-5QD) | 9.07 ± 0.44 | 8.48 ± 0.38 | 8.16 ± 0.24 | 0.59 ± 0.45 | 0.191 | − 0.31 ± 0.46 | 0.503 | − 0.9 ± 0.46 | 0.051 |
T0, baseline; T1, 12 weeks; T2, 16 weeks